Showing results (141-150 of 305) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi surveyCorrado Tarella, Manuela Zanni, Michele Magni, et al.
Critical Reviews in Oncology/Hematology|July 2, 2011
Primary plasma cell leukemia in the era of new drugs: has something changed?Pellegrino Musto, Livio Pagano, Maria Teresa Petrucci, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesisFlavia Pichiorri, Sung-Suk Suh, Marco Ladetto, et al.
Oncotarget|December 2, 2016
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemiaValentina Griggio, Giorgia Mandili, Candida Vitale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation SequencingMattia D'Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.
Leukemia|July 25, 2018
European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasiasMaria Gavriatopoulou, Pellegrino Musto, Jo Caers, et al.
Annals of Hematology|June 6, 2013
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphomaSimone Ferrero, Luigia Monitillo, Barbara Mantoan, et al.
Blood|August 31, 2012
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cellsMarta Coscia, Candida Vitale, Silvia Peola, et al.
Blood|February 28, 2004
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disordersMarco Ladetto, Mara Compagno, Irene Ricca, et al.
Haematologica|July 28, 2018
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)Sara Bringhen, Alberto Milan, Claudio Ferri, et al.
Pageof 31